Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. nonselective COX-2 inhibitors

British Journal of Clinical Pharmacology

Volumn 69, Issue 3, 2010, Pages 303-306

  Renda, Giulia ^a   Zurro, Maria ^a   Romano, Mario ^a   De Caterina, Raffaele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

Author keywords

Aspirin; Celecoxib; Cyclooxygenase 2; Ibuprofen; Lipoxin

Indexed keywords

15 EPI LIPOXIN A4; ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2; IBUPROFEN; LIPOXIN A; PLACEBO; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; EPIGASTRIC PAIN; ERYTHEMA; FATTY ACID METABOLISM; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; ISCHEMIC HEART DISEASE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; NAUSEA; OSTEOARTHRITIS; PHASE 4 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN PRURITUS; STOMACH PROTECTION; URINALYSIS; VOMITING;

AGED; ASPIRIN; CYCLOOXYGENASE 2 INHIBITORS; DRUG THERAPY, COMBINATION; HUMANS; IBUPROFEN; LIPOXINS; MIDDLE AGED; MYOCARDIAL ISCHEMIA; OSTEOARTHRITIS; PLACEBO EFFECT; PYRAZOLES; SULFONAMIDES;

EID: 76649132058     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2009.03579.x     Document Type: Article

References (11)

1. Fiorucci S, Santucci L, Wallace JL, Sardina M, Romano M, del Soldato P, Morelli A. Interaction of a selective cyclooxygenase-2 inhibitor with aspirin and NO-releasing aspirin in the human gastric mucosa. Proc Natl Acad Sci USA 2003 100 : 10937 10941.
2. Fiorucci S, de Lima OM Jr., Mencarelli A, Palazzetti B, Distrutti E, McKnight W, Dicay M, Ma L, Romano M, Morelli A, Wallace JL. Cyclooxygenase-2- derived lipoxin A4 increases gastric resistance to aspirin-induced damage. Gastroenterology 2002 123 : 1598 1606.
3. Serhan CN, Oliw E. Unorthodox routes to prostanoid formation: new twists in cyclooxygenase-initiated pathways. J Clin Invest 2001 107 : 1481 1489.
4. Claria J, Serhan CN. Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 1995 92 : 9475 9479.
5. Chiang N, Takano T, Clish CB, Petasis NA, Tai HH, Serhan CN. Aspirin-triggered 15-epi-lipoxin A4 (ATL) generation by human leukocytes and murine peritonitis exudates: development of a specific 15-epi-LXA4 ELISA. J Pharmacol Exp Ther 1998 287 : 779 790.
6. Fiorucci S, Distrutti E, de Lima OM, Romano M, Mencarelli A, Barbanti M, Palazzini E, Morelli A, Wallace JL. Relative contribution of acetylated cyclo-oxygenase (COX)-2 and 5-lipooxygenase (LOX) in regulating gastric mucosal integrity and adaptation to aspirin. FASEB J 2003 17 : 1171 1173.
7. Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Clin Pharmacol Ther 2006 80 : 264 274.
8. Romano M, Luciotti G, Gangemi S, Marinucci F, Prontera C, D'Urbano E, Davi G. Urinary excretion of lipoxin A(4) and related compounds: development of new extraction techniques for lipoxins. Lab Invest 2002 82 : 1253 1254.
9. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Nishi SP, Martinez JD, Huang MH, Uretsky BF, Perez-Polo JR. Augmentation of myocardial production of 15-epi-lipoxin-a4 by pioglitazone and atorvastatin in the rat. Circulation 2006 114 : 929 935.
10. Birnbaum Y, Ye Y, Lin Y, Freeberg SY, Huang MH, Perez-Polo JR, Uretsky BF. Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart. Prostaglandins Other Lipid Mediat 2007 83 : 89 98.
11. Titos E, Chiang N, Serhan CN, Romano M, Gaya J, Pueyo G, Claria J. Hepatocytes are a rich source of novel aspirin-triggered 15-epi-lipoxin A(4). Am J Physiol 1999 277 : C870 7.